Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wang

Showing results (471-480 of 603) with videos related to

Pageof 61
Sort By:
Annals of Internal Medicine|July 23, 2014
Fluid resuscitation in sepsis: a systematic review and network meta-analysisBram Rochwerg, Waleed Alhazzani, Anees Sindi, et al.
British Journal of Haematology|March 29, 2019
Lenalidomide plus rituximab (R<sup>2</sup> ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trialMelody R Becnel, Loretta J Nastoupil, Felipe Samaniego, et al.
Molecular Cancer Therapeutics|August 31, 2013
In vitro and in vivo therapeutic efficacy of carfilzomib in mantle cell lymphoma: targeting the immunoproteasomeLiang Zhang, Lan V Pham, Kate J Newberry, et al.
British Journal of Haematology|April 14, 2016
Clinical activity of carfilzomib correlates with inhibition of multiple proteasome subunits: application of a novel pharmacodynamic assaySusan J Lee, Konstantin Levitsky, Francesco Parlati, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2010
Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myelomaYvonne A Efebera, Sofia R Qureshi, Suzanne M Cole, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplantMuzaffar H Qazilbash, Rima M Saliba, Bilal Ahmed, et al.
Nature Communications|May 8, 2026
Non-contact laser polishing and reconstruction towards high-efficiency all-perovskite tandem solar cellsTianjun Ma, Dingfu Luo, Wenjiang Ye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2023
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design StudyMichael Wang, Tanya Siddiqi, Leo I Gordon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myelomaGaurav C Parikh, Ali Imran Amjad, Rima M Saliba, et al.
Blood|May 5, 2017
Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphomaJohn Kuruvilla, Michael Savona, Rachid Baz, et al.
Pageof 61

Showing results (471-480 of 603) with videos related to

Sort By:
Pageof 61
Annals of Internal Medicine|July 23, 2014
Fluid resuscitation in sepsis: a systematic review and network meta-analysisBram Rochwerg, Waleed Alhazzani, Anees Sindi, et al.
British Journal of Haematology|March 29, 2019
Lenalidomide plus rituximab (R<sup>2</sup> ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trialMelody R Becnel, Loretta J Nastoupil, Felipe Samaniego, et al.
Molecular Cancer Therapeutics|August 31, 2013
In vitro and in vivo therapeutic efficacy of carfilzomib in mantle cell lymphoma: targeting the immunoproteasomeLiang Zhang, Lan V Pham, Kate J Newberry, et al.
British Journal of Haematology|April 14, 2016
Clinical activity of carfilzomib correlates with inhibition of multiple proteasome subunits: application of a novel pharmacodynamic assaySusan J Lee, Konstantin Levitsky, Francesco Parlati, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2010
Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myelomaYvonne A Efebera, Sofia R Qureshi, Suzanne M Cole, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplantMuzaffar H Qazilbash, Rima M Saliba, Bilal Ahmed, et al.
Nature Communications|May 8, 2026
Non-contact laser polishing and reconstruction towards high-efficiency all-perovskite tandem solar cellsTianjun Ma, Dingfu Luo, Wenjiang Ye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2023
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design StudyMichael Wang, Tanya Siddiqi, Leo I Gordon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myelomaGaurav C Parikh, Ali Imran Amjad, Rima M Saliba, et al.
Blood|May 5, 2017
Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphomaJohn Kuruvilla, Michael Savona, Rachid Baz, et al.
Pageof 61